HARARE – CAPS Holdings, Zimbabwe’s largest pharmaceutical group, urgently requires $6 million in recapitalisation funds, with the drug-maker currently operating at five...
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions